Русский
Human immunodeficiency virus in the Russian Federation in 2023
DOI: https://dx.doi.org/10.18565/epidem.2024.14.3.21-9
Pokrovsky V.V., Ladnaia N.N.
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
Materials and methods. The data of federal statistical surveillance forms No. 2, No. 4, Rospotrebnadzor monitoring form «Information on measures to prevent HIV infection, hepatitis B and C, detection and treatment of HIV patients» and personalized information on identified cases of HIV infection in Russia (form No. 266 u~88) were analyzed.
Results. In 2023, 58,740 new HIV cases were registered, 7% less than in 2022. A significant number of new HIV cases were detected among the rural population and residents of remote regions. The number of tests conducted increased to 48,914,663, mainly due to testing of population groups without a specific risk of HIV infection, while testing of HIV-vulnerable population groups decreased, which could lead to a decrease in the number of new cases. At the same time, mass screening of the population made it possible to identify many HIV-positive people, which ensured their access to timely treatment. 77.6% of newly diagnosed HIV-positive respondents named heterosexual contacts as the only risk factor for infection, 17.7% also mentioned drug use, and 3.7% reported homosexual contacts. One of the reasons for the persistent level of HIV transmission was the insufficient coverage of patients with effective antiretroviral therapy.
Conclusion. In 2023, the spread of HIV infection in Russia continued with the same intensity as in the previous 3 years, which leads to a gradual increase in the prevalence of HIV among the population.
Literature
1. Latest global and regional statistics on the status of the AIDS epidemic. Fact sheet. UNAIDS, 2024. https://www.unaids.org/en/resources/ documents/2024/UNAIDS_FactSheet 2. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2023–2022 data. Stockholm: ECDC/WHO; 2023. https://www.ecdc.europa.eu/en/publications-data/ hivaids-surveillance-europe-2023-2022-data 3. HIV-testing, PrPep, new HIV diagnosis and care outcomes for people accessing HIV services. UK Health Security Agency, 2023 report. https://www.gov.uk/government/statistics/hiv-annual-data-tables/hiv-testing-prep-new-hiv-diagnoses-and-care-outcomes-for-people-accessing-hiv-services-2023-report 4. Покровский В.В. Эпидемиология и профилактика ВИЧ-инфекции и СПИД. М.: Медицина, 1996. 247 с. Pokrovsky V.V. [Epidemiology and prevention of HIV infection and AIDS]. Moscow: Medicine, 1996. 247 p. (In Russ.). 5. Соколова Е.В., Ладная Н.Н., Покровский В.В., Кравченко А.В., Козырина Н.В., Юрин О.Г. и др. Влияние антиретровирусной терапии на развитие эпидемии ВИЧ-инфекции в Российской Федерации. Эпидемиол. инфекц. болезни. Актуал. вопр. 2023; 13(3): 20–6. DOI: 10.18565/epidem.2023.13.3.20-6 Sokolova E.V., Ladnaia N.N., Pokrovsky V.V., Kravchenko A.V., Kozyrina N.V., Yurin O.G. et al. [Impact of antiretroviral therapy on the development of the HIV-infection epidemic in the Russian Federation]. Epidemiol. infectious diseases. Current items 2023; 13(3): 20–6. (In Russ.). DOI: 10.18565/epidem.2023.13.3.20-6 6. Ладная Н. Н., Покровский В.В. Профилактический эффект лечения больных ВИЧ-инфекцией в России. Сб. трудов XVI Ежегодного Всероссийского Конгресса по инфекционным болезням имени академика В.И. Покровского, Москва, 25–27 марта 2024 г. М.: Медицинское маркетинговое агентство; 2024: 114. Ladnaia N.N., Pokrovsky V.V. [Preventive effect of treatment of patients with HIV infection in Russia. Collection of proceedings of the XVI Annual All-Russian Congress on Infectious Diseases named after Academician V.I. Pokrovsky], Moscow, March 25–27, 2024. Moscow: Medical Marketing Agency, 2024: 114. (In Russ.).
About the Autors
Professor Vadim V. Pokrovsky, Academician of the Russian Academy of Sciences, MD, Head, HIV department, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, Moscow, Russia; pokrovsky.vad@yandex.ru; https://orcid.org/0000-0002-9514-7288; Scopus Author ID: 7202457043
Natalia N. Ladnaia, Cand. Biol. Sci., Senior Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, Moscow, Russia; ladnaia@hotmail.com; htpp://orcid.org/0000-0003-2994-151X
Similar Articles
